authors
- Keshteli, Ammar Hassanzadeh
- Madsen, Karen L
- Mandal, Rupasri
- Boeckxstaens, Guy E
- Bercik, Premysl
- De Palma, Giada
- Reed, David E
- Wishart, David
- Vanner, Stephen
- Dieleman, Levinus A
Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors’ reply
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 2019
has subject area
- 1103 Clinical Sciences (FoR)
- 1115 Pharmacology and Pharmaceutical Sciences (FoR)
- Adenocarcinoma (MeSH)
- Biomarkers (MeSH)
- Colitis, Ulcerative (MeSH)
- Colorectal Neoplasms (MeSH)
- Gastroenterology & Hepatology (Science Metrix)
- Gastrointestinal Microbiome (MeSH)
- Humans (MeSH)
- Irritable Bowel Syndrome (MeSH)